Future Outlook of the Global Bone Scan Market
While oncology remains a major driver, the Bone Scan Market is diversifying into areas such as rheumatology, orthopedics, and sports medicine.
In 2023, the market was valued at USD 825 million and is projected to grow to USD 1.35 billion by 2032. Rising sports injuries, autoimmune bone disorders, and chronic arthritis cases are expanding scan applications beyond cancer diagnostics.
This diversification ensures broader adoption, with the Bone Scan Market evolving into a multi-specialty diagnostic tool.